Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anish Thomas

Showing results (151-160 of 167) with videos related to

Pageof 17
Sort By:
EMBO Molecular Medicine|July 26, 2023
ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancerChristopher W Schultz, Yang Zhang, Rajaa Elmeskini, et al.
Science Translational Medicine|January 28, 2021
Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapiesCamille Tlemsani, Nobuyuki Takahashi, Lorinc Pongor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trialAriel Lopez-Chavez, Anish Thomas, Arun Rajan, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
D-type cyclins regulate DNA mismatch repair in the G1 and S phases of the cell cycle, maintaining genome stabilityGergely Rona, Bearach Miwatani-Minter, Qingyue Zhang, et al.
Cold Spring Harbor Molecular Case Studies|December 1, 2016
Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment responseRomi Biswas, Shaojian Gao, Constance M Cultraro, et al.
EMBO Molecular Medicine|February 17, 2024
Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancerChristopher W Schultz, Yang Zhang, Rajaa Elmeskini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2025
Advances in Lung Cancer Basic and Translational Research in 2025 - Overview and Perspectives Focusing on NSCLCCeline Mascaux, Triparna Sen, Montse Sanchez-Cespedes, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
Lamin A/C Deficiency Drives Genomic Instability and Poor Survival in Small-Cell Lung Cancer through Increased R-loop AccumulationChristopher W Schultz, Sourav Saha, Anjali Dhall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2023
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical TrialMelissa L Abel, Nobuyuki Takahashi, Cody Peer, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2025
Lamin A/C loss promotes R-loop-mediated genomic instability and poor survival in small-cell lung cancerChristopher W Schultz, Sourav Saha, Anjali Dhall, et al.
Pageof 17

Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
EMBO Molecular Medicine|July 26, 2023
ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancerChristopher W Schultz, Yang Zhang, Rajaa Elmeskini, et al.
Science Translational Medicine|January 28, 2021
Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapiesCamille Tlemsani, Nobuyuki Takahashi, Lorinc Pongor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trialAriel Lopez-Chavez, Anish Thomas, Arun Rajan, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
D-type cyclins regulate DNA mismatch repair in the G1 and S phases of the cell cycle, maintaining genome stabilityGergely Rona, Bearach Miwatani-Minter, Qingyue Zhang, et al.
Cold Spring Harbor Molecular Case Studies|December 1, 2016
Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment responseRomi Biswas, Shaojian Gao, Constance M Cultraro, et al.
EMBO Molecular Medicine|February 17, 2024
Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancerChristopher W Schultz, Yang Zhang, Rajaa Elmeskini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2025
Advances in Lung Cancer Basic and Translational Research in 2025 - Overview and Perspectives Focusing on NSCLCCeline Mascaux, Triparna Sen, Montse Sanchez-Cespedes, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
Lamin A/C Deficiency Drives Genomic Instability and Poor Survival in Small-Cell Lung Cancer through Increased R-loop AccumulationChristopher W Schultz, Sourav Saha, Anjali Dhall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2023
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical TrialMelissa L Abel, Nobuyuki Takahashi, Cody Peer, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2025
Lamin A/C loss promotes R-loop-mediated genomic instability and poor survival in small-cell lung cancerChristopher W Schultz, Sourav Saha, Anjali Dhall, et al.
Pageof 17